Literature DB >> 11064676

An investigation of the Peutz-Jeghers gene (LKB1) in sporadic breast and colon cancers.

L F Forster1, S Defres, D R Goudie, D U Baty, F A Carey.   

Abstract

AIMS: To explore the role of the Peutz-Jeghers gene (LKB1) in sporadic breast and colon cancers.
METHODS: Thirty consecutive sporadic carcinomas of the breast and 23 of the colon were selected. DNA was extracted from paraffin wax embedded tissue and analysed for loss of heterozygosity (LOH) at microsatellite markers D19S886 and D19S565 close to the LKB1 gene. Tumours showing LOH were screened for LKB1 mutations by single strand conformational polymorphism (SSCP).
RESULTS: Five breast carcinomas showed LOH (21% and 7% of those informative for D19S886 and D19S565, respectively). Five of the colorectal carcinomas showed LOH (15% and 36% of those informative for D19S886 and D19S565, respectively), with one sample showing allele loss with both markers. Screening of these 10 carcinomas by SSCP identified one migrational shift but sequencing revealed an intronic polymorphism only. Therefore, no coding mutations were found in these carcinomas.
CONCLUSIONS: These findings suggest that although allele loss at the LKB1 locus occurs relatively frequently in sporadic breast and colon cancers, mutations do not seem to be a feature.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11064676      PMCID: PMC1731085          DOI: 10.1136/jcp.53.10.791

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

Review 1.  Mouse models of inherited cancer syndromes.

Authors:  Sohail Jahid; Steven Lipkin
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

2.  Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization.

Authors:  Johanna I Partanen; Anni I Nieminen; Tomi P Mäkelä; Juha Klefstrom
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

3.  STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas.

Authors:  N Sato; C Rosty; M Jansen; N Fukushima; T Ueki; C J Yeo; J L Cameron; C A Iacobuzio-Donahue; R H Hruban; M Goggins
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 4.  LKB1: Can We Target an Hidden Target? Focus on NSCLC.

Authors:  Gloriana Ndembe; Ilenia Intini; Elisa Perin; Mirko Marabese; Elisa Caiola; Paolo Mendogni; Lorenzo Rosso; Massimo Broggini; Marika Colombo
Journal:  Front Oncol       Date:  2022-05-11       Impact factor: 5.738

5.  No association between promoter polymorphism of STK11 gene and lung cancer risk in the Korean population.

Authors:  Jae Sook Sung; Young Mi Whang; Kyong Hwa Park; Jeong-Seon Ryu; Jong Gwon Choi; Jae Hong Seo; Sang Won Shin; Jun Suk Kim; Yeul Hong Kim
Journal:  Cancer Res Treat       Date:  2009-12-31       Impact factor: 4.679

Review 6.  Breaking the epithelial polarity barrier in cancer: the strange case of LKB1/PAR-4.

Authors:  Johanna I Partanen; Topi A Tervonen; Juha Klefström
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-09-23       Impact factor: 6.237

Review 7.  From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions.

Authors:  Catherine G Fischer; Laura D Wood
Journal:  J Pathol       Date:  2018-12       Impact factor: 7.996

8.  IgG based immunome analyses of breast cancer patients reveal underlying signaling pathways.

Authors:  István Gyurján; Sandra Rosskopf; Johana A Luna Coronell; Daniela Muhr; Christian Singer; Andreas Weinhäusel
Journal:  Oncotarget       Date:  2019-05-28

9.  Loss of LKB1 Protein Expression Correlates with Increased Risk of Recurrence and Death in Patients with Resected, Stage II or III Colon Cancer.

Authors:  Maria Sfakianaki; Chara Papadaki; Maria Tzardi; Maria Trypaki; Sardar Alam; Eleni D Lagoudaki; Ippokratis Messaritakis; Odysseas Zoras; Dimitris Mavroudis; Vassilis Georgoulias; John Souglakos
Journal:  Cancer Res Treat       Date:  2019-03-20       Impact factor: 4.679

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.